Showing results (1581-1590 of 3,015) with videos related to

Sort By:
Pageof 302
Clinical Kidney Journal|February 25, 2022
Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort studyMasanori Abe, Ikuto Masakane, Atsushi Wada, et al.
Clinical Kidney Journal|February 25, 2022
The relationship between chronic kidney disease-associated pruritus and health-related quality of life: a systematic reviewEdith Poku, Sue Harnan, Gill Rooney, et al.
Clinical Kidney Journal|February 25, 2022
Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathySong-Tao Feng, Yang Yang, Jin-Fei Yang, et al.
Clinical Kidney Journal|July 27, 2022
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney diseaseEsben Iversen, Thomas Kallemose, Mads Hornum, et al.
Clinical Kidney Journal|July 27, 2022
Baseline characteristics and evolution of Brazilian patients with atypical hemolytic uremic syndrome: first report of the Brazilian aHUS RegistryMaria Helena Vaisbich, Luís Gustavo Modelli de Andrade, Precil Diego Miranda de Menezes Neves, et al.
Clinical Kidney Journal|July 27, 2022
Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patientsMaria Luz Sánchez-Tocino, Emilio González-Parra, Blanca Miranda Serrano, et al.
Clinical Kidney Journal|July 27, 2022
DLEU7-AS1 promotes renal cell cancer by silencing the miR-26a-5p/coronin-3 axisXin-Jun Wang, Lin Chen, Ran Xu, et al.
Clinical Kidney Journal|October 4, 2021
Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degenerationGautam Phadke, Ramy M Hanna, Antoney Ferrey, et al.
Clinical Kidney Journal|March 2, 2022
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patientsDavide Bolignano, Evangelia Dounousi, Pierangela Presta, et al.
Clinical Kidney Journal|June 15, 2019
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?Beatriz Fernandez-Fernandez, Raul Fernandez-Prado, Jose Luis Górriz, et al.
Pageof 302